End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
4.4
CNY
|
-1.12%
|
|
+3.77%
|
-12.35%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,344
|
4,530
|
10,288
|
6,972
|
5,569
|
4,881
|
-
|
-
|
Enterprise Value (EV)
1 |
4,344
|
4,530
|
10,288
|
6,972
|
5,569
|
4,881
|
4,881
|
4,881
|
P/E ratio
|
13.4
x
|
18.6
x
|
17.8
x
|
20.6
x
|
16.7
x
|
11.9
x
|
10.7
x
|
10
x
|
Yield
|
2.67%
|
5.12%
|
1.13%
|
-
|
2.99%
|
4.32%
|
4.55%
|
5%
|
Capitalization / Revenue
|
1.08
x
|
1.28
x
|
2.03
x
|
-
|
0.99
x
|
0.84
x
|
0.83
x
|
0.82
x
|
EV / Revenue
|
1.08
x
|
1.28
x
|
2.03
x
|
-
|
0.99
x
|
0.84
x
|
0.83
x
|
0.82
x
|
EV / EBITDA
|
-
|
-
|
10.7
x
|
-
|
7.14
x
|
4.97
x
|
4.67
x
|
4.4
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.64
x
|
1.65
x
|
3.34
x
|
-
|
1.58
x
|
1.3
x
|
1.22
x
|
1.14
x
|
Nbr of stocks (in thousands)
|
1,158,507
|
1,158,507
|
1,158,507
|
1,167,757
|
1,109,431
|
1,109,431
|
-
|
-
|
Reference price
2 |
3.750
|
3.910
|
8.880
|
5.970
|
5.020
|
4.400
|
4.400
|
4.400
|
Announcement Date
|
2/28/20
|
2/17/21
|
3/9/22
|
3/30/23
|
4/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,014
|
3,538
|
5,067
|
-
|
5,622
|
5,796
|
5,853
|
5,962
|
EBITDA
1 |
-
|
-
|
965.5
|
-
|
780.1
|
982
|
1,045
|
1,109
|
EBIT
1 |
384.6
|
305.5
|
643.2
|
-
|
402
|
497
|
547
|
593
|
Operating Margin
|
9.58%
|
8.64%
|
12.69%
|
-
|
7.15%
|
8.57%
|
9.35%
|
9.95%
|
Earnings before Tax (EBT)
1 |
383.2
|
305
|
643.5
|
-
|
401.2
|
497
|
547
|
593
|
Net income
1 |
327.1
|
252.6
|
575
|
332.1
|
349.2
|
433
|
476
|
516
|
Net margin
|
8.15%
|
7.14%
|
11.35%
|
-
|
6.21%
|
7.47%
|
8.13%
|
8.65%
|
EPS
2 |
0.2800
|
0.2100
|
0.5000
|
0.2900
|
0.3000
|
0.3700
|
0.4100
|
0.4400
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.2000
|
0.1000
|
-
|
0.1500
|
0.1900
|
0.2000
|
0.2200
|
Announcement Date
|
2/28/20
|
2/17/21
|
3/9/22
|
3/30/23
|
4/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
11.7%
|
8.7%
|
19%
|
-
|
9.77%
|
11%
|
11.3%
|
11.5%
|
ROA (Net income/ Total Assets)
|
6.27%
|
4.43%
|
8.55%
|
-
|
-
|
5.75%
|
6.11%
|
6.38%
|
Assets
1 |
5,218
|
5,703
|
6,727
|
-
|
-
|
7,530
|
7,791
|
8,088
|
Book Value Per Share
2 |
2.290
|
2.370
|
2.660
|
-
|
3.170
|
3.390
|
3.610
|
3.850
|
Cash Flow per Share
2 |
0.5900
|
0.3100
|
0.1500
|
-
|
0.6900
|
0.8200
|
0.8300
|
0.8700
|
Capex
1 |
494
|
690
|
515
|
-
|
184
|
387
|
404
|
415
|
Capex / Sales
|
12.31%
|
19.52%
|
10.16%
|
-
|
3.28%
|
6.68%
|
6.9%
|
6.96%
|
Announcement Date
|
2/28/20
|
2/17/21
|
3/9/22
|
3/30/23
|
4/14/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -12.35% | 674M | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +4.67% | 32.41B | | +6.59% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B | | -14.74% | 13.81B |
Other Commodity Chemicals
|